Tapewire

NYSE · USD

JNJ

JOHNSON & JOHNSON

Export transactions ↓
Tapewire entity
2722
SEC CIK
0000200406
Parsed reports
1,771

Last 12 months

Inside the activity.

1 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202602
Feb 2026015
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202607
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 27, 2026 Filed Mar 3, 2026 21:21 UTC
Decker Robert JVP Corporate Controller
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 4,075 $0.00 Strike: $115.67 $0.00
Disclosure

SEC source: 0000200406-26-000048 · wk-form4_1772572907.xml · derivative · entry 5

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,075 shares

Expires 2027-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:21 UTC
Decker Robert JVP Corporate Controller
SaleCommon Stock 4,075 $247.87 $1,010,070.25
Disclosure

SEC source: 0000200406-26-000048 · wk-form4_1772572907.xml · nonDerivative · entry 2

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,682

Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:21 UTC
Decker Robert JVP Corporate Controller
Exercise / conversionCommon Stock 4,075 $115.67 $471,355.25
Disclosure

SEC source: 0000200406-26-000048 · wk-form4_1772572907.xml · nonDerivative · entry 1

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,757

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 20, 2026 Filed Feb 23, 2026 22:20 UTC
Schmid TimothyEVP, WW Chair, MedTech
SaleCommon Stock 1,322 $245.66 $324,762.52
Disclosure

SEC source: 0000200406-26-000046 · wk-form4_1771885218.xml · nonDerivative · entry 1

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,447

Read SEC document
February 18, 2026 Filed Feb 19, 2026 02:11 UTC
Schmid TimothyEVP, WW Chair, MedTech
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 8,998 $0.00 Strike: $129.51 $0.00
Disclosure

SEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 22

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,998 shares

Expires 2028-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F13 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 02:11 UTC
Schmid TimothyEVP, WW Chair, MedTech
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 13,625 $0.00 Strike: $115.67 $0.00
Disclosure

SEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 21

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,625 shares

Expires 2027-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F13 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 02:11 UTC
Schmid TimothyEVP, WW Chair, MedTech
SaleCommon Stock 8,998 $244.53 $2,200,280.94
Disclosure

SEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 12

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,769

Read SEC document
February 18, 2026 Filed Feb 19, 2026 02:11 UTC
Schmid TimothyEVP, WW Chair, MedTech
Exercise / conversionCommon Stock 8,998 $129.51 $1,165,330.98
Disclosure

SEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 11

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,767

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 02:11 UTC
Schmid TimothyEVP, WW Chair, MedTech
SaleCommon Stock 13,625 $244.20 $3,327,225.00
Disclosure

SEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 10

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,769

F7 · price: This transaction was executed in multiple trades at prices ranging from $244.20 to $244.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 02:11 UTC
Schmid TimothyEVP, WW Chair, MedTech
Exercise / conversionCommon Stock 13,625 $115.67 $1,576,003.75
Disclosure

SEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 9

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,394

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:11 UTC
Broadhurst VanessaEVP, Global Corp Affairs
SaleCommon Stock 6,197 $243.39 $1,508,287.83
Disclosure

SEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · nonDerivative · entry 9

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,003

F7 · price: This transaction was executed in multiple trades at prices ranging from $243.39 to $243.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
REED JOHN CEVP, Innovative Medicine, R&D
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 29,927 $0.00 Strike: $156.15 $0.00
Disclosure

SEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · derivative · entry 15

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,854

Underlying: Common Stock · 29,927 shares

Expires 2035-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
REED JOHN CEVP, Innovative Medicine, R&D
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 21,721 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · derivative · entry 14

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,721

Underlying: Common Stock · 21,721 shares

Expires 2034-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
REED JOHN CEVP, Innovative Medicine, R&D
SaleCommon Stock 2,283 $243.00 $554,769.00
Disclosure

SEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 9

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,658

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
REED JOHN CEVP, Innovative Medicine, R&D
SaleCommon Stock 29,927 $243.00 $7,272,261.00
Disclosure

SEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 8

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,941

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
REED JOHN CEVP, Innovative Medicine, R&D
Exercise / conversionCommon Stock 29,927 $156.15 $4,673,101.05
Disclosure

SEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 7

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,868

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
REED JOHN CEVP, Innovative Medicine, R&D
SaleCommon Stock 21,721 $243.00 $5,278,203.00
Disclosure

SEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 6

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,941

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
REED JOHN CEVP, Innovative Medicine, R&D
Exercise / conversionCommon Stock 21,721 $157.92 $3,430,180.32
Disclosure

SEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 5

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,662

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
Wolk Joseph JExec VP, CFO
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 33,386 $0.00 Strike: $131.94 $0.00
Disclosure

SEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · derivative · entry 26

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 33,386 shares

Expires 2029-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F16 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
Wolk Joseph JExec VP, CFO
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 12,066 $0.00 Strike: $129.51 $0.00
Disclosure

SEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · derivative · entry 25

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,066 shares

Expires 2028-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F16 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
Wolk Joseph JExec VP, CFO
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 19,241 $0.00 Strike: $115.67 $0.00
Disclosure

SEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · derivative · entry 24

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,241 shares

Expires 2027-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F16 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
Wolk Joseph JExec VP, CFO
SaleCommon Stock 24,961 $242.68 $6,057,535.48
Disclosure

SEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 15

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,000

F10 · price: This transaction was executed in multiple trades at prices ranging from $242.59 to $242.815. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
Wolk Joseph JExec VP, CFO
SaleCommon Stock 33,386 $242.75 $8,104,451.50
Disclosure

SEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 14

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,961

F9 · price: This transaction was executed in multiple trades at prices ranging from $242.71 to $242.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
Wolk Joseph JExec VP, CFO
Exercise / conversionCommon Stock 33,386 $131.94 $4,404,948.84
Disclosure

SEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 13

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,347

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
Wolk Joseph JExec VP, CFO
SaleCommon Stock 12,066 $242.87 $2,930,469.42
Disclosure

SEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 12

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,961

F8 · price: This transaction was executed in multiple trades at prices ranging from $242.85 to $242.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
Wolk Joseph JExec VP, CFO
Exercise / conversionCommon Stock 12,066 $129.51 $1,562,667.66
Disclosure

SEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 11

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,027

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
Wolk Joseph JExec VP, CFO
SaleCommon Stock 19,241 $242.99 $4,675,370.59
Disclosure

SEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 10

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,961

F7 · price: This transaction was executed in multiple trades at prices ranging from $242.94 to $243.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC
Wolk Joseph JExec VP, CFO
Exercise / conversionCommon Stock 19,241 $115.67 $2,225,606.47
Disclosure

SEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 9

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,202

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 20,521 $0.00 Strike: $164.62 $0.00
Disclosure

SEC source: 0000200406-26-000044 · wk-form4_1771467149.xml · derivative · entry 23

Swanson James D. · CIK 0001904785 · EVP, CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,521 shares

Expires 2031-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vested and was exercisable on the third anniversary of the grant date.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC SaleCommon Stock 20,521 $242.70 $4,980,446.70
Disclosure

SEC source: 0000200406-26-000044 · wk-form4_1771467149.xml · nonDerivative · entry 14

Swanson James D. · CIK 0001904785 · EVP, CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,698.131

F9 · price: This transaction was executed in multiple trades at prices ranging from $242.69 to $242.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 02:12 UTC Exercise / conversionCommon Stock 20,521 $164.62 $3,378,167.02
Disclosure

SEC source: 0000200406-26-000044 · wk-form4_1771467149.xml · nonDerivative · entry 13

Swanson James D. · CIK 0001904785 · EVP, CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,219.131

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Broadhurst VanessaEVP, Global Corp Affairs
GrantRestricted Share Units · Derivative 1,034 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · derivative · entry 15

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,034

Underlying: Common Stock · 1,034 shares

Expires not disclosed

F10 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F10 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F10 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F11 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Broadhurst VanessaEVP, Global Corp Affairs
GrantEmployee Stock Options (Right to Buy) · Derivative 14,405 $0.00 Strike: $243.45 $0.00
Disclosure

SEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · derivative · entry 14

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,405

Underlying: Common Stock · 14,405 shares

Expires 2036-02-15

F9 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Exercise / conversionRestricted Share Units · Derivative 526 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · derivative · entry 13

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,050

Underlying: Common Stock · 526 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F8 · balance_after: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Exercise / conversionRestricted Share Units · Derivative 492 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · derivative · entry 12

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 491

Underlying: Common Stock · 492 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F8 · balance_after: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Tax withholdingCommon Stock 270 $243.45 $65,731.50
Disclosure

SEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · nonDerivative · entry 8

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,200

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Exercise / conversionCommon Stock 526 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · nonDerivative · entry 7

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,470

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Tax withholdingCommon Stock 252 $243.45 $61,349.40
Disclosure

SEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · nonDerivative · entry 6

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,944

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Exercise / conversionCommon Stock 492 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · nonDerivative · entry 5

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,196

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
GrantRestricted Share Units · Derivative 9,459 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · derivative · entry 16

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,459

Underlying: Common Stock · 9,459 shares

Expires not disclosed

F10 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F10 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F10 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F8 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
GrantEmployee Stock Options (Right to Buy) · Derivative 131,734 $0.00 Strike: $243.45 $0.00
Disclosure

SEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · derivative · entry 15

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,734

Underlying: Common Stock · 131,734 shares

Expires 2036-02-15

F9 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Exercise / conversionRestricted Share Units · Derivative 4,505 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · derivative · entry 14

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,008

Underlying: Common Stock · 4,505 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F8 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Exercise / conversionRestricted Share Units · Derivative 3,682 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · derivative · entry 13

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,682

Underlying: Common Stock · 3,682 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F8 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Tax withholdingCommon Stock 1,960 $243.45 $477,162.00
Disclosure

SEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · nonDerivative · entry 8

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 324,447

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Exercise / conversionCommon Stock 4,505 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · nonDerivative · entry 7

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 326,407

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Tax withholdingCommon Stock 1,602 $243.45 $390,006.90
Disclosure

SEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · nonDerivative · entry 6

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321,902

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Exercise / conversionCommon Stock 3,682 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · nonDerivative · entry 5

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,504

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Schmid TimothyEVP, WW Chair, MedTech
GrantRestricted Share Units · Derivative 2,548 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 20

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,548

Underlying: Common Stock · 2,548 shares

Expires not disclosed

F12 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F12 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F12 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F10 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Schmid TimothyEVP, WW Chair, MedTech
GrantEmployee Stock Options (Right to Buy) · Derivative 35,489 $0.00 Strike: $243.45 $0.00
Disclosure

SEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 19

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,489

Underlying: Common Stock · 35,489 shares

Expires 2036-02-15

F11 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 02:11 UTC
Schmid TimothyEVP, WW Chair, MedTech
Exercise / conversionRestricted Share Units · Derivative 1,026 $0.00 $0.00
Disclosure

SEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 18

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,051

Underlying: Common Stock · 1,026 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.

F10 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.